Actinium Pharmaceuticals, Inc. (ATNM) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -5.87M | -5.29M | -6.33M | -5.39M | -7.57M | -5.75M | -11.97M | -7.97M | -7.37M | -7.49M | -11.13M | -13.64M |
| Operating CF Margin % | - | - | -7027.78% | - | - | - | - | - | - | -9246.91% | - | - |
| Operating CF Growth % | 22.5% | 8.03% | 47.18% | 32.36% | -2.71% | 23.22% | -7.64% | 41.57% | 51.09% | 3.7% | -94.66% | -148.87% |
| Net Income | -5.52M | -5.94M | -5.13M | -6.88M | -15.94M | -6.65M | -11.57M | -11.35M | -8.67M | -9.32M | -13.28M | -15.18M |
| Depreciation & Amortization | 220K | 206K | 206K | 204K | 205K | 204K | 202K | 189K | 216K | 199K | 200K | 209K |
| Stock-Based Compensation | 0 | 10K | 109K | 197K | 8.87M | 1.2M | 1.34M | 1.37M | 1.38M | 927K | 921K | 1M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.52M | -1.81M | -142K |
| Other Non-Cash Items | 11K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.52M | 1.81M | 142K |
| Working Capital Changes | -579K | 435K | -1.51M | 1.08M | -715K | -506K | -1.95M | 1.82M | -298K | 708K | 1.03M | 328K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -661K | 997K | -1.49M | 1.19M | -1.05M | 371K | -1.98M | 1.66M | -440K | -196K | -488K | 1.28M |
| Cash from Investing | -2K | -104K | 0 | 0 | 0 | 0 | 0 | 0 | -11K | 0 | -30K | -47K |
| Capital Expenditures | -2K | -104K | 0 | 0 | 0 | 0 | 0 | 0 | -11K | 0 | -30K | -47K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -3K | -3K | -209K | -3K | -2K | -3K | 4.6M | 9.95M | 14.77M | 1.19M | 2.86M | 10.05M |
| Debt Issued (Net) | -3K | -3K | -2K | -3K | -2K | -2K | -2K | -3K | -2K | -1K | -1K | -1K |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | -1K | 4.6M | 9.96M | 14.7M | 1.19M | 2.86M | 9.79M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -207K | 0 | 0 | 0 | 0 | 0 | 75K | 0 | 0 | 261K |
| Net Change in Cash | -5.87M | -5.39M | -6.54M | -5.39M | -7.58M | -5.75M | -7.38M | 1.98M | 7.38M | -6.3M | -8.29M | -3.64M |
| Free Cash Flow | -5.87M | -5.39M | -6.33M | -5.39M | -7.57M | -5.75M | -11.97M | -7.97M | -7.38M | -7.49M | -11.15M | -13.69M |
| FCF Margin % | - | - | -7027.78% | - | - | - | - | - | - | -9246.91% | - | - |
| FCF Growth % | 22.47% | 6.22% | 47.18% | 32.36% | -2.56% | 23.22% | -7.35% | 41.77% | 51.26% | 3.9% | -92.73% | -149.52% |
| FCF per Share | -0.19 | -0.17 | -0.20 | -0.17 | -0.24 | -0.18 | -0.39 | -0.26 | -0.26 | -0.27 | -0.41 | -0.52 |
| FCF Conversion (FCF/Net Income) | 1.06x | 0.89x | 1.23x | 0.78x | 0.48x | 0.86x | 1.04x | 0.70x | 0.85x | 0.80x | 0.84x | 0.90x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |